Trials / Completed
CompletedNCT03549143
Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
Detailed description
Awareness about the disease in Russia is extremely low both among doctors and especially among patients. To date there are no data on the prevalence of the disease in Russia. This is the first study to show patient profile, main trigger factors and concomitant diseases among patients with Irritable Bowel Syndrome (IBS) in Russia. Also treatment characteristics for these patients in Russia will be measured. This study fills a lack of scientific data about prevalence of IBS and additional information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | IBS | No intervention, description of routine practice only |
Timeline
- Start date
- 2017-12-25
- Primary completion
- 2019-04-19
- Completion
- 2019-04-19
- First posted
- 2018-06-07
- Last updated
- 2019-04-25
Locations
37 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT03549143. Inclusion in this directory is not an endorsement.